ReviewExpert review of medical devices2020
Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy.
Review in Expert review of medical devices, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07348432 (The diabEAT Study), which is not on this map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes
Who cites it
31 citing papers in PubMed.
- Trial
- Perceptions of adults with type 1 diabetes mellitus about diabetes management and exercise.Human factors in healthcare · 2026Article
- Physical activity and hybrid closed loop technology in adults with type 1 diabetes mellitus - what are the challenges experienced by the users and how are these met? A qualitative interview study.BMC endocrine disorders · 2026Article
- Comparative efficacy and safety of insulin pump versus multiple daily injections in early-stage diabetic nephropathy: a systematic review and meta-analysis.Translational andrology and urology · 2026Review
- Closed-Loop Bioelectronic Artificial Pancreas Patch for Continuous Monitoring and Regulation of Blood Glucose in Diabetic Rats and Pigs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Revolutionizing Diabetes Management Through Nanotechnology-Driven Smart Systems.Pharmaceutics · 2025Review
- Successful use of a fully closed-loop insulin delivery system in an adolescent with diabetes secondary to pancreatitis - a case report.Annals of pediatric endocrinology & metabolism · 2025Article
- Transforming Healthcare: Intelligent Wearable Sensors Empowered by Smart Materials and Artificial Intelligence.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Safety of Options to "Boost" (Enhancing Insulin Infusion Rates) and "Ease-Off" (Reducing Insulin Infusion Rates) in CamAPS FX Hybrid Closed-Loop System: A Real-World Analysis.Diabetes technology & therapeutics · 2025Article
- Global research trends in AI-assisted blood glucose management: a bibliometric study.Frontiers in endocrinology · 2025Review
- Closed-loop systems: recent advancements and lived experiences.Expert review of medical devices · 2024Review
- Unmet needs in the treatment of type 1 diabetes: why is it so difficult to achieve an improvement in metabolic control?Nutrition & diabetes · 2024Review
- Article
- Recent advances in the precision control strategy of artificial pancreas.Medical & biological engineering & computing · 2024Review
- Article
- Insulin detection in diabetes mellitus: challenges and new prospects.Nature reviews. Endocrinology · 2023Review
- Hypoglycemia Detection Using Hand Tremors: Home Study of Patients With Type 1 Diabetes.JMIR diabetes · 2023Article
- Article
- Virtual twin for healthcare management.Frontiers in digital health · 2023Article
- Type 1 diabetes - What's new in prevention and therapeutic strategies?Pediatric endocrinology, diabetes, and metabolism · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionType 1 diabetes is a lifelong disease with high management burden. The majority of people with type 1 diabetes fail to achieve glycemic targets. Algorithm-driven automated insulin delivery (closed-loop) systems aim to address these challenges. This review provides an overview of commercial and emerging closed-loop systems. AREAS COVERED: We review safety and efficacy of commercial and emerging hybrid closed-loop systems. A literature search was conducted and clinical trials using day-and-night closed-loop systems during free-living conditions were used to report on safety data. We comment on efficacy where robust randomized controlled trial data for a particular system are available. We highlight similarities and differences between commercial systems. EXPERT OPINION: Study data shows that hybrid closed-loop systems are safe and effective, consistently improving glycemic control when compared to standard therapy. While a fully closed-loop system with minimal burden remains the end-goal, these hybrid closed-loop systems have transformative potential in diabetes care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.